Blocking angiotensin II Type 1 receptor triggers apoptotic cell death in human pancreatic cancer cells.
about
Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research DatabaseA multicenter phase II trial of gemcitabine and candesartan combination therapy in patients with advanced pancreatic cancer: GECA2.The prognostic significance of hypertension at diagnosis in children with wilms tumor.Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitorsSunitinib combined with angiotensin-2 type-1 receptor antagonists induces more necrosis: a murine xenograft model of renal cell carcinoma.Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine.Telmisartan induces apoptosis and regulates Bcl-2 in human renal cancer cells.Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: a retrospective examinationAngiotensin peptides and lung cancer.Angiotensin II type-1 receptor blockers enhance the effects of bevacizumab-based chemotherapy in metastatic colorectal cancer patients.Expression and clinical significance of angiotensin II type 1 receptor in human hepatocellular carcinoma.Olmesartan potentiates the anti-angiogenic effect of sorafenib in mice bearing Ehrlich's ascites carcinoma: role of angiotensin (1-7)Mesenchymal cell proliferation and programmed cell death: key players in fibrogenesis and new targets for therapeutic intervention.Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence.LOX-1 and angiotensin receptors, and their interplay.The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer.The angiotensin II type I receptor blocker olmesartan inhibits the growth of pancreatic cancer by targeting stellate cell activities in mice.Impact of Angiotensin Receptor Blocker Use on Overall Survival Among Patients Undergoing Resection for Pancreatic Cancer.Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study.Management of Adverse Events Associated with Cabozantinib Therapy in Renal Cell Carcinoma.
P2860
Q28730234-E251F75F-E0D7-4EFB-A809-01CC45C5CEFCQ33407858-DCA6AEAB-C369-4C9D-89FE-14DF4958EADEQ33552390-793063F9-D5BA-4A91-9381-D4546D9B1AABQ33698419-C26AA97C-80BB-4EA1-8A1B-54576E635E25Q33745382-910BED14-7101-4B1E-A0C8-8A1772730921Q34363486-180FD4C8-7F74-4F17-A501-BE994B642844Q34433686-42DE39C0-F9B8-45D3-97D9-6ADF7D318D89Q35219246-F204713D-98D3-4FB4-88C0-0B264CB19DFCQ35857462-D6C7239E-F40A-4F51-88ED-E3273F0032A5Q36335456-9282DCB7-2BD1-40A9-86A6-1FA6C5723D49Q37434424-7F62E690-7F0B-48AC-906C-368FE55225DCQ37505197-8A2C9CE8-4706-4305-9C88-6860D246BA6AQ37828318-E3C74E3B-A089-48B3-824D-D5F6DF609E39Q37864617-BEBAB308-A2CD-4EF2-A8C7-8FA55D3882A6Q37921158-BB1AF784-DE7E-475D-A6F2-49F2CCF9DCE2Q38404425-4AEBB87E-A248-42D4-8BCB-2C6565D3C73AQ39182740-D48A37E1-0334-46EF-92FF-0F3DBC7E9545Q40462627-FCACBC0B-A6C1-4898-84E2-D078112E4ED6Q47626689-9098E3BD-120F-4665-AECF-083FCA48C8FAQ49953442-10D587E9-683F-455C-8A50-F2D09D80A67E
P2860
Blocking angiotensin II Type 1 receptor triggers apoptotic cell death in human pancreatic cancer cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Blocking angiotensin II Type 1 ...... human pancreatic cancer cells.
@en
Blocking angiotensin II Type 1 ...... human pancreatic cancer cells.
@nl
type
label
Blocking angiotensin II Type 1 ...... human pancreatic cancer cells.
@en
Blocking angiotensin II Type 1 ...... human pancreatic cancer cells.
@nl
prefLabel
Blocking angiotensin II Type 1 ...... human pancreatic cancer cells.
@en
Blocking angiotensin II Type 1 ...... human pancreatic cancer cells.
@nl
P2093
P1433
P1476
Blocking angiotensin II Type 1 ...... human pancreatic cancer cells.
@en
P2093
Charles J Yeo
Galina Chipitsyna
Hwyda A Arafat
Molly Davis
Qiaoke Gong
P304
P356
10.1097/MPA.0B013E3181C314CD
P577
2010-07-01T00:00:00Z